OLEMA PHARMACEUTICALS INC (OLMA)
US68062P1066 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 68.54M | 23.70M | 13.80M | 338.50M | 100.00K | |||
| Marketable Securities | 193.27M | 180.70M | 273.40M | N/A | N/A | |||
| Receivables | 673.00K | 300.00K | N/A | N/A | N/A | |||
| Other Current Assets | 4.03M | 4.20M | 3.40M | 3.50M | 0.00 | |||
| Total Current Assets | 266.51M | 208.90M | 290.70M | 342.10M | 100.00K | |||
| Non-Current Assets | ||||||||
| PPE Net | 3.26M | 4.00M | 4.70M | 100.00K | 0.00 | |||
| Other Non-Current Assets | 7.17M | 2.80M | 500.00K | 500.00K | 0.00 | |||
| Total Non-Current Assets | 10.43M | 6.70M | 5.20M | 600.00K | 0.00 | |||
| TOTAL ASSETS | 276.94M | 215.60M | 295.90M | 342.70M | 100.00K | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 18.85M | 16.00M | 8.50M | 3.50M | 0.00 | |||
| Accounts Payable | 2.70M | 400.00K | 0.00 | 700.00K | 900.00K | |||
| Other Current Liabilities | 73.00K | 200.00K | 500.00K | 400.00K | 400.00K | |||
| Total Current Liabilities | 21.62M | 16.50M | 9.00M | 4.60M | 1.40M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 1.43M | 1.60M | 2.40M | N/A | N/A | |||
| Total Non-Current Liabilities | 1.43M | 1.60M | 2.40M | 0.00 | 0.00 | |||
| TOTAL LIABILITIES | 23.05M | 18.10M | 11.40M | 4.60M | 1.40M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -305.63M | -209.00M | -104.20M | -33.10M | -10.80M | |||
| Additional Paid In Capital | 559.18M | 408.30M | 388.90M | 371.20M | 200.00K | |||
| Common Shares | 4.00K | 0.00 | 0.00 | 0.00 | 9.30M | |||
| Other Shareholders' Equity | 347.00K | -1.80M | -100.00K | N/A | N/A | |||
| Shares Outstanding | 54.99M | 40.30M | 39.80M | 39.30M | 38.50M | |||
| Tangible Book Value per Share | 4.62 | 4.90 | 7.15 | 8.60 | -0.27 | |||
| Total Shareholders' Equity | 253.90M | 197.50M | 284.60M | 338.10M | -1.20M | |||
| TOTAL LIABILITIES AND EQUITY | 276.94M | 215.60M | 295.90M | 342.70M | 100.00K | |||
| Statistics | ||||||||
| Current Ratio | 12.33 | 12.66 | 32.30 | 74.37 | 0.07 | |||
| Return On Assets (ROA) | -34.90% | -48.60% | -24.03% | -7.00% | -4320.00% | |||
| Return On Equity (ROE) | -38.07% | -53.06% | -24.98% | -7.10% | N/A | |||
All data in USD